Frequent polymorphic variations but rare tumour specific mutations of the S100A2 on 1q21 in non-small cell lung cancer

Lung Cancer

Volumn 63, Issue 3, 2009, Pages 354-359

  Stražišar, Mojca ^a   Rott, Tomaž ^a   Glavač, Damjan ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

mRNA expression; Non small cell lung carcinoma; Polymorphisms; Q23X mutation; S100A2 gene

Indexed keywords

PROTEIN P53; PROTEIN S 100; S100 A2 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHROMOSOME 1Q; DNA EXTRACTION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; ONCOGENE K RAS; PRIORITY JOURNAL; RNA EXTRACTION; SCREENING TEST; SOMATIC MUTATION; SQUAMOUS CELL CARCINOMA; TISSUE SECTION;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTACTIC FACTORS; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE FREQUENCY; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, GENETIC; S100 PROTEINS;

EID: 59249101552     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2008.06.005     Document Type: Article

References (15)

1. Heizmann C.W., Fritz G., and Schafer B.W. S100 proteins: structure, functions and pathology. Front Biosci 7 (2002) d1356-d1368
2. Glenney Jr. J.R., Kindy M.S., and Zokas L. Isolation of a new member of the S100 protein family: amino acid sequence, tissue, and subcellular distribution. J Cell Biol 108 (1989) 569-578
3. Lee S.W., Tomasetto C., Swisshelm K., Keyomarsi K., and Sager R. Down-regulation of a member of the S100 gene family in mammary carcinoma cells and reexpression by azadeoxycytidine treatment. Proc Natl Acad Sci USA 89 (1992) 2504-2508
4. Matsubara D., Niki T., Ishikawa S., Goto A., Ohara E., Yokomizo T., et al. Differential expression of S100A2 and S100A4 in lung adenocarcinomas: clinicopathological significance, relationship to p53 and identification of their target genes. Cancer Sci 96 (2005) 844-857
5. Mueller A., Schafer B.W., Ferrari S., Weibel M., Makek M., Hochli M., et al. The calcium-binding protein S100A2 interacts with p53 and modulates its transcriptional activity. J Biol Chem 280 (2005) 29186-29193
6. Tsai W.C., Tsai S.T., Jin Y.T., and Wu L.W. Cyclooxygenase-2 is involved in S100A2-mediated tumor suppression in squamous cell carcinoma. Mol Cancer Res 4 (2006) 539-547
7. Diederichs S., Bulk E., Steffen B., Ji P., Tickenbrock L., Lang K., et al. S100 family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer. Cancer Res 64 (2004) 5564-5569
8. Heighway J., Knapp T., Boyce L., Brennand S., Field J.K., Betticher D.C., et al. Expression profiling of primary non-small cell lung cancer for target identification. Oncogene 21 (2002) 7749-7763
9. Smith S.L., Gugger M., Hoban P., Ratschiller D., Watson S.G., Field J.K., et al. S100A2 is strongly expressed in airway basal cells, preneoplastic bronchial lesions and primary non-small cell lung carcinomas. Br J Cancer 91 (2004) 1515-1524
10. Wang H., Zhang Z., Li R., Ang K.K., Zhang H., Caraway N.P., et al. Overexpression of S100A2 protein as a prognostic marker for patients with stage I non small cell lung cancer. Int J Cancer 116 (2005) 285-290
11. Feng G., Xu X., Youssef E.M., and Lotan R. Diminished expression of S100A2, a putative tumor suppressor, at early stage of human lung carcinogenesis. Cancer Res 61 (2001) 7999-8004
12. Wicki R., Franz C., Scholl F.A., Heizmann C.W., and Schäfer B.W. Repression of the candidate tumor suppressor gene S100A2 in breast cancer is mediated by site-specific hypermethylation. Cell Calcium 4 (1997) 243-254
13. Yamanoshita O., Kubota T., Hou J., Ping Y.M., Zhang X.L., Li X.P., et al. DHPLC is superior to SSCP in screening p53 mutations in esophageal cancer tissues. Int J Cancer 114 (2005) 74-79
14. König E.A., Köves I., Raşinariu A., Popp A.R., Kusser W.C., Soyonki K., et al. Alterations of K-RAS and p53 mutations in colorectal cancer patients in Central Europe. J Toxicol Environ Health A 62 (2001) 333-347
15. Gupta S., Hussain T., MacLennan G.T., Fu P., Patel J., and Mukhtar H. Differential expression of S100A2 and S100A4 during progression of human prostate adenocarcinoma. J Clin Oncol 21 (2003) 106-112